Propofol use in endoscopic retrograde cholangiopancreatography and endoscopic ultrasound.
Compared to standard endoscopy, endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) are often lengthier and more complex, thus requiring higher doses of sedatives for patient comfort and compliance. The aim of this review is to provide the reader with information regarding the use, safety profile, and merits of propofol for sedation in advanced endoscopic procedures like ERCP and EUS, based on the current literature.
Danny G Cheriyan, Michael F Byrne, Department of Gastroenterology, University of British Columbia, Vancouver General Hospital, Vancouver, BC V5Z 1M9, Canada.
Danny G
DG
Cheriyan
Danny G Cheriyan, Michael F Byrne, Department of Gastroenterology, University of British Columbia, Vancouver General Hospital, Vancouver, BC V5Z 1M9, Canada.
Michael F
MF
Byrne
D018686:Anesthetics, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000191:economics; D016292:Procedural Sedation / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D019160:Endosonography / Q000191:economics; D006801:Humans; D015742:Propofol / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics; D012307:Risk Factors
D018686:Anesthetics, Intravenous; D015742:Propofol
Endoscopic ultrasound; Endoscopy; Ndoscopic retrograde cholangiopancreatography; Propofol; Safety